No Clinically Significant Drug-Drug Interactions With Coadministration of Feminizing or Masculinizing Hormone Therapy and Twice-Yearly Lenacapavir PrEP in Gender-Diverse Persons

Conference Reports for NATAP

ID Week 2025
October 19-22
Atlanta, GA


No Clinically Significant Drug-Drug Interactions With Coadministration of Feminizing or Masculinizing Hormone Therapy and Twice-Yearly Lenacapavir PrEP in Gender-Diverse Persons

	IDWeek; October 19-22, 2025; Atlanta, GA, USA